Find Saralasin manufacturers, exporters & distributors on PharmaCompass

Saralasin Acetate, Anhydrous

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

FINISHED DOSAGE FORMULATIONS

1 FDF Dossiers, 1 FDA Orange Book

1 FDF Dossiers
1 FDA Orange Book

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Saralasin acetate hydrate, Saralasin acetate [usan], 39698-78-7, Saralasin acetate (usan), Sarenin, Unii-fo21z580m4

Molecular Formula

C₄₄H₇₁N₁₃O₁₃

Molecular Weight

990.1 g/mol

InChI Key

YBZYNINTWCLDQA-UHKVWXOHSA-N

An octapeptide analog of angiotensin II (bovine) with amino acids 1 and 8 replaced with sarcosine and alanine, respectively. It is a highly specific competitive inhibitor of angiotensin II that is used in the diagnosis of HYPERTENSION.

1 2D Structure

Saralasin

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

acetic acid;(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[2-(methylamino)acetyl]amino]pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]propanoic acid;hydrate

2.1.2 InChI

InChI=1S/C42H65N13O10.C2H4O2.H2O/c1-22(2)33(53-35(58)28(50-32(57)20-45-6)9-7-15-47-42(43)44)38(61)51-29(17-25-11-13-27(56)14-12-25)36(59)54-34(23(3)4)39(62)52-30(18-26-19-46-21-48-26)40(63)55-16-8-10-31(55)37(60)49-24(5)41(64)65;1-2(3)4;/h11-14,19,21-24,28-31,33-34,45,56H,7-10,15-18,20H2,1-6H3,(H,46,48)(H,49,60)(H,50,57)(H,51,61)(H,52,62)(H,53,58)(H,54,59)(H,64,65)(H4,43,44,47);1H3,(H,3,4);1H2/t24-,28-,29-,30-,31-,33-,34-;;/m0../s1

2.1.3 InChI Key

YBZYNINTWCLDQA-UHKVWXOHSA-N

2.1.4 Canonical SMILES

CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C(C)C)C(=O)NC(CC2=CN=CN2)C(=O)N3CCCC3C(=O)NC(C)C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)CNC.CC(=O)O.O

2.1.5 Isomeric SMILES

C[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC3=CC=C(C=C3)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC.CC(=O)O.O

2.2 Synonyms

2.2.1 MeSH Synonyms

1. (sar(1),ala(8))angii

2. (sar1,val5,ala8)angiotensin Ii

3. 1 Sar 8 Ala Angiotensin Ii

4. 1 Sarcosine 8 Alanine Angiotensin Ii

5. 1-sar-8-ala Angiotensin Ii

6. 1-sarcosine-8-alanine Angiotensin Ii

7. Angiotensin Ii, 1-sar-8-ala

8. Angiotensin Ii, 1-sarcosine-8-alanine

9. Angiotensin Ii, Sar(1)-ala(8)-

10. Angiotensin Ii, Sarcosyl(1)-alanine(8)-

11. Anhydrous Saralasin Acetate

12. Hydrated Saralasin Acetate

13. Sar-arg-val-tyr-val-his-pro-ala

14. Saralasin

15. Saralasin Acetate, Anhydrous

16. Saralasin Acetate, Hydrated

2.2.2 Depositor-Supplied Synonyms

1. Saralasin Acetate Hydrate

2. Saralasin Acetate [usan]

3. 39698-78-7

4. Saralasin Acetate (usan)

5. Sarenin

6. Unii-fo21z580m4

7. Sarenin (tn)

8. Saralasin Hydrated Acetate

9. Schembl2200145

10. Chembl1200670

11. Fo21z580m4

12. N-(1-(n-(n-(n-(n-(n2-(n-methylglycyl-l-arginyl)-l-l-valyl)-l-tyrosyl)-l-valyl)-l-histidyl)-l-prolyl)-l-alanine Acetate (salt) Hydrate

13. Saralasin Acetate(34273-10-4 Free Base)

14. D04126

15. Q27278095

16. [sar1, Val5, Ala8]-angiotensin Ii Acetate Salt Hydrate, >=97% (hplc), Powder

17. Angiotensin Ii, 1-(n-methylglycine)-5-l-valine-8-l-alanine-, Acetate (salt) Hydrate

18. N-(1-(n-(n-(n-(n-(n(sup 2)-(n-methylglycyl-l-arginyl)-l-valyl)-l-tyrosyl)-l-valyl)-l-histidyl)-l-prolyl)-l-alanine Acetate (salt) Hydrate

2.3 Create Date

2006-11-22

3 Chemical and Physical Properties

Molecular Formula	C₄₄H₇₁N₁₃O₁₃
Molecular Weight	990.1 g/mol
Hydrogen Bond Donor Count	14
Hydrogen Bond Acceptor Count	16
Rotatable Bond Count	25
Exact Mass	989.52942937 g/mol
Monoisotopic Mass	989.52942937 g/mol
Topological Polar Surface Area	396 Å²
Heavy Atom Count	70
Formal Charge	0
Complexity	1700
Isotope Atom Count	0
Defined Atom Stereocenter Count	7
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	3

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Angiotensin II Type 1 Receptor Blockers

Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. Some are used as ANTIHYPERTENSIVE AGENTS. (See all compounds classified as Angiotensin II Type 1 Receptor Blockers.)

FDF Dossiers